We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Avoid Simultaneous Administration in Phase I Studies
Avoid Simultaneous Administration in Phase I Studies
November 28, 2007
The tragic results of the TGN1412 gene therapy clinical trial in the UK in March 2006 continue to reverberate in new European regulations for Phase I or first-in-human studies although many researchers think the only problem with that study was the simultaneous administration of the investigational drug.